TST-004

N/A

Report date: 2024/04/15 15:42:42

Base Information

Drug NameTST-004
Drug Alias NameTST-004AP-302
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionMannan-binding lectin serine protease 2 inhibitors
TargetsMannan-binding lectin serine protease 2
Therapy Area/IndicationsGlomerulonephritis, IGA
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPreclinical
Originator CompaniesSuzhou Transcenta Therapeutics Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAlebund Pharmaceuticals (Hong Kong) LtdTranscenta Holding Ltd
Inactive CompaniesN/A
Active IndicationsGlomerulonephritis, IGA
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A